Safety and Immunogenicity Study of GSK Biologicals Tuberculosis Vaccines (692342) to Healthy Adults

PHASE2

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

BIOLOGICAL: GSK Biologicals' AS01B adjuvant
BIOLOGICAL: GSK Biologicals' Candidate Tuberculosis Vaccine (692342) - Formulation 1
BIOLOGICAL: GSK Biologicals' Candidate Tuberculosis Vaccine (692342) - Formulation 2
BIOLOGICAL: GSK Biologicals' Candidate Tuberculosis Vaccine (692342) - Formulation 3
BIOLOGICAL: GSK Biologicals' Candidate Tuberculosis Vaccine (692342) - Formulation 4 - Dosage 1
BIOLOGICAL: GSK Biologicals' Candidate Tuberculosis Vaccine (692342) - Formulation 4 - Dosage 2

GlaxoSmithKline